929875-41-2

Downstream Products

• 929875-43-4 {benzyl-[2-(1-{[6-(2-hydroxy-ethyl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl]-amino}-2-phenyl-ethyl)-oxazol-5-yl]-amino}-acetic acid methyl ester 
• 929875-42-3 {benzyl-[2-(1-{[6-(2-hydroxy-ethyl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl]-amino}-heptyl)-oxazol-5-yl]-amino}-acetic acid methyl ester 
• 881304-13-8 [benzyl-(2-{1-[({[(2-hydroxy-ethylcarbamoyl)-methyl]-carbamoyl}-methyl)-methyl-amino]-heptyl}-oxazol-5-yl)-amino]-acetic acid methyl ester 
• 929875-46-7 (benzyl-{2-[6-benzyloxycarbonylamino-1-({6-[(2-hydroxy-ethylcarbamoyl)-methyl]-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl}-amino)-hexyl]-oxazol-5-yl}-amino)-acetic acid methyl ester 

Relevant academic research and scientific papers

5-Aminooxazole as an internal traceless activator of C-terminal carboxylic acid: Rapid access to diversely functionalized cyclodepsipeptides

A conceptually novel macrolactonization protocol has been developed. It is a domino process involving a sequence of: 1) protonation of 5-aminooxazole leading to the electrophilic iminium salt; 2) trapping of the iminium species by the neighboring C-termin